BOTHELL, Wash., May 14, 2025 -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the company will be participating in the following investor conferences:
- 22nd Annual Craig-Hallum Institutional Investor Conference
- May 28, 2025
- Minneapolis, MN at the Renaissance Hotel
- Benchmark 2025 Healthcare House Call Virtual Conference
- May 29, 2025
- Virtual
- Jefferies Global Life Sciences Conference
- June 3 – 5, 2025
- New York, NY at the Marriott Marquis
- Wolfe Research Small & Mid-Cap Conference
- June 5, 2025
- New York, NY at Wolfe Headquarters
- Northland Growth Conference 2025
- June 25, 2025
- Virtual
About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.
Media & Investor Relations
At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com
Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
